RKV
$0.455
-1.087%

Rakovina Therapeutics Inc.
News & Events

Last updated: Sep 3, 2025, 7:40 PM ET

  1. Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

    GlobeNewswire AUG 28, 2025 6:12 PM EDT
    VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE
  2. Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis

    GlobeNewswire AUG 26, 2025 4:00 AM EDT
    VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE
  3. Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies

    GlobeNewswire AUG 12, 2025 4:00 AM EDT
    VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina ...
    READ ARTICLE
  4. Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre

    GlobeNewswire JUL 30, 2025 4:00 AM EDT
    VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE
  5. Rakovina Therapeutics Announces Stock Option Grants

    GlobeNewswire JUL 29, 2025 5:00 PM EDT
    VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: ...
    READ ARTICLE
  6. Rakovina Therapeutics Announces Warrant Exercise Incentive Program

    GlobeNewswire JUL 24, 2025 5:00 PM EDT
    VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: ...
    READ ARTICLE
  7. Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

    GlobeNewswire JUL 23, 2025 4:00 AM EDT
    VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE
  8. Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access

    GlobeNewswire JUL 15, 2025 4:00 AM EDT
    VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE
  9. Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC's 2025 Emerging Biotech Company of the Year Award

    GlobeNewswire JUL 11, 2025 9:56 AM EDT
    VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) --  Rakovina Therapeutics Inc. (...
    READ ARTICLE
  10. Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development

    GlobeNewswire JUL 10, 2025 4:00 AM EDT
    VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...
    READ ARTICLE

Upcoming Events

Get notified of Rakovina Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available